Drug intelligence / Profile preview

EyePromise RESTORE

Development stage: Discontinued
Lead developer: ZeaVision
Administration: Oral

Overview

EyePromise RESTORE is a nutritional supplement developed by ZeaVision, Inc. It is designed to augment macular pigment levels in the eye. This supplement has been investigated for its potential to improve dark adaptation in older adults with normal vision and those with early age-related macular degeneration, aiming to enhance overall visual function.

Brand names: EyePromise RESTORE
Other names: RESTORE

Beyond the preview

Go deeper on EyePromise RESTORE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EyePromise RESTORE.

Explore the full profile